The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 10, 2016

Filed:

Dec. 18, 2009
Applicants:

Zoltán Konthur, Berlin, DE;

Hans Lehrach, Berlin, DE;

Karl Skriner, Berlin, DE;

Inventors:

Zoltán Konthur, Berlin, DE;

Hans Lehrach, Berlin, DE;

Karl Skriner, Berlin, DE;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G01N 33/564 (2006.01); G01N 33/68 (2006.01); C07K 16/44 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6875 (2013.01); G01N 33/564 (2013.01); C07K 16/44 (2013.01); C07K 2317/34 (2013.01); C07K 2317/41 (2013.01); G01N 2440/18 (2013.01); G01N 2800/102 (2013.01); G01N 2800/104 (2013.01);
Abstract

The present invention pertains to a diagnostic assay for the diagnosis of an autoimmune disease. The present invention provides an improved diagnostic assay for the diagnosis of an autoimmune disease, particularly rheumatoid arthritis (RA) and Systemic Lupus Erythematosus (SLE). In particular the invention pertains to a method of determining in a sample of a subject the presence of two or more antibodies comprising the step of determining whether an antibody is present in a sample that specifically recognizes a hnRNP-DL polypeptide or a fragment thereof or a splice variant thereof and the further step of determining whether at least one further antibody is present in the sample that specifically recognizes a at least one other hnRNP polypeptide which is not sequence homologue to said hnRNP-DL polypeptide or fragments thereof or splice variants thereof, and/or said CCP peptide and/or a polypeptide comprising at least the Fc-part of IgG, respectively. The invention also relates to polypeptides, protein sets and antibodies that may be used in such methods and assays and for therapeutic use in RA and SLE patients.


Find Patent Forward Citations

Loading…